![Andreas Grauer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Grauer
Technik-/Wissenschafts-/F&E-Leiter bei
SAGIMET BIOSCIENCES INC.
Vermögen: - $ am 31.05.2026
Profil
Andreas Grauer is currently Chief Medical Officer at Federation Bio, Inc. since 2021 and will be Chief Medical Officer at Sagimet Biosciences, Inc. starting in 2026.
Former positions include Chief Medical Officer at Corcept Therapeutics, Inc. from 2019 to 2021, Vice President-Global Development at Amgen, Inc. from 2007 to 2018, Global Executive Medical Director at Procter & Gamble Pharmaceuticals, Inc. from 2000 to 2007, and Chief Medical Officer & Vice President at Omeros Corp.
Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Andreas Grauer
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.04.2026 |
Federation Bio, Inc.
 Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
Ehemalige bekannte Positionen von Andreas Grauer
| Unternehmen | Position | Ende |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2021 |
| AMGEN INC. | Corporate Officer/Principal | 01.12.2018 |
Procter & Gamble Pharmaceuticals, Inc.
 Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
| OMEROS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Andreas Grauer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Federation Bio, Inc.
Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics | Health Technology |
